Safety and tolerability of primaquine used for radical cure of Plasmodium vivax in Ethiopia

The main objective of this evaluation is to actively assess the safety and tolerability of administering primaquine for radical cure of P. vivax malaria without G6PD testing through haemoglobin and adverse events monitoring.

The Principal Investigator is Yemane Berhane.

For more information please visit: https://mesamalaria.org/mesa-track/safety-and-tolerability-primaquine-used-radical-cure-plasmodium-vivax-ethiopia